The Health Resources and Services Administration quickly finalized a regulation to push up implementation of the 340B ceiling price and penalties rule to Jan. 1, saying the action will not interfere with HHS’ overall drug-pricing strategy and HRSA can continue with additional 340B rulemaking after the ceiling price and penalties regulation has been implemented. Earlier this year the agency said it was delaying the rule in part due to the broader drug-pricing discussions , and partially to allow the agency...